Amelioration of lacrimal gland inflammation by oral administration of K-13182 in Sjögren's syndrome model mice

Clinical and Experimental Immunology

Volumn 149, Issue 3, 2007, Pages 586-595

  Nishiyama, T ^a,b,c   Mishima, K ^a   Obara, K ^a   Inoue, H ^a   Doi, T ^c   Kondo, S ^c   Saka, M ^c   Tabunoki, Y ^c   Hattori, Y ^c   Kodama, T ^d   Tsubota, K ^b   Saito, I ^a  

^a TSURUMI UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c KOWA COMPANY LTD   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoimmune disease; Endothelial cells; Lacrimal gland; NOD mouse; VCAM 1

Indexed keywords

ANTIINFLAMMATORY AGENT; FAS LIGAND; GRANZYME A; K 13182; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL ADHESION; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME REPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LACRIMAL GLAND DISEASE; LACRIMATION; MALE; MONONUCLEAR CELL; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SJOEGREN SYNDROME; THERAPY EFFECT;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL ADHESION; CELLS, CULTURED; DACRYOCYSTITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED NOD; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SJOGREN'S SYNDROME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 34547901768     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2007.03448.x     Document Type: Article

References (40)

1. Fox RI, Saito I. Criteria for diagnosis of Sjogren's syndrome. Rheum Dis Clin North Am 1994 20 : 391 407.
2. Kang HI, Fei HM, Saito I et al. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjogren's syndrome. J Immunol 1993 150 : 3615 23.
3. Fox RI, Chilton T, Scott S, Benton L, Howell FV, Vaughan JH. Potential role of Epstein-Barr virus in Sjogren's syndrome. Rheum Dis Clin North Am 1987 13 : 275 92.
4. Fox RI, Pearson G, Vaughan JH. Detection of Epstein-Barr virus-associated antigens and DNA in salivary gland biopsies from patients with Sjogren's syndrome. J Immunol 1986 137 : 3162 8.
5. Saito I, Servenius B, Compton T, Fox RI. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 1989 169 : 2191 8.
6. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 : 301 14.
7. Nakashima Y, Raines EW, Plump AS, Breslow JL, Ross R. Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse. Arterioscler Thromb Vasc Biol 1998 18 : 842 51.
8. O'Brien KD, Allen MD, McDonald TO et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest 1993 92 : 945 51.
9. Morales-Ducret J, Wayner E, Elices MJ, Alvaro-Gracia JM, Zvaifler NJ, Firestein GS. Alpha 4/beta 1 integrin (VLA-4) ligands in arthritis. Vascular cell adhesion molecule-1 expression in synovium and on fibroblast-like synoviocytes. J Immunol 1992 149 : 1424 31.
10. Saito I, Terauchi K, Shimuta M et al. Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal 1993 7 : 180 7.
11. Nakajima H, Sano H, Nishimura T, Yoshida S, Iwamoto I. Role of vascular cell adhesion molecule 1/very late activation antigen 4 and intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 interactions in antigen-induced eosinophil and T cell recruitment into the tissue. J Exp Med 1994 179 : 1145 54.
12. Nishiyama T, Mishima K, Ide F et al. Functional analysis of an established mouse vascular endothelial cell line. J Vasc Res 2007 44 : 138 48.
13. Kaneko M, Hayashi J, Saito I, Miyasaka N. Probucol downregulates E-selectin expression on cultured human vascular endothelial cells. Arterioscler Thromb Vasc Biol 1996 16 : 1047 51.
14. Kaneko M, Inoue H, Nakazawa R et al. Pirfenidone induces intercellular adhesion molecule-1 (ICAM-1) down-regulation on cultured human synovial fibroblasts. Clin Exp Immunol 1998 113 : 72 6.
15. Umetani M, Nakao H, Doi T et al. A novel cell adhesion inhibitor, K-7174, reduces the endothelial VCAM-1 induction by inflammatory cytokines, acting through the regulation of GATA. Biochem Biophys Res Commun 2000 272 : 370 4.
16. Delporte C, O'Connell BC, He X et al. Increased fluid secretion after adenoviral-mediated transfer of the aquaporin-1 cDNA to irradiated rat salivary glands. Proc Natl Acad Sci USA 1997 94 : 3268 73.
17. White SC, Casarett GW. Induction of experimental autoallergic sialadenitis. J Immunol 1974 112 : 178 85.
18. Mikulowska-Mennis A, Xu B, Berberian JM, Michie SA. Lymphocyte migration to inflamed lacrimal glands is mediated by vascular cell adhesion molecule-1/alpha(4) beta(1) integrin, peripheral node addressin/1-selectin, and lymphocyte function-associated antigen-1 adhesion pathways. Am J Pathol 2001 159 : 671 81.
19. Toda I, Sullivan BD, Rocha EM, Da Silveira LA, Wickham LA. Sullivan DA. Impact of gender on exocrine gland inflammation in mouse models of Sjogren's syndrome. Exp Eye Res 1999 69 : 355 66.
20. Tsubota K, Fujita H, Tadano K et al. Improvement of lacrimal function by topical application of CyA in murine models of Sjogren's syndrome. Invest Ophthalmol Vis Sci 2001 42 : 101 10.
21. Kong L, Robinson CP, Peck AB et al. Inappropriate apoptosis of salivary and lacrimal gland epithelium of immunodeficient NOD-scid mice. Clin Exp Rheumatol 1998 16 : 675 81.
22. Nakano H, Doi T, Suda M et al. An inhibitor of VCAM-1 expression and its implication as a novel treatment of inflammatory diseases. J Atheroscler Thromb 1998 4 : 149 55.
23. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J Biol Chem 1992 267 : 16323 9.
24. Neish AS, Read MA, Thanos D, Pine R, Maniatis T, Collins T. Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 1995 15 : 2558 69.
25. Neish AS, Khachigian LM, Park A, Baichwal VR, Collins T. Sp1 is a component of the cytokine-inducible enhancer in the promoter of vascular cell adhesion molecule-1. J Biol Chem 1995 270 : 28903 9.
26. Lechleitner S, Gille J, Johnson DR, Petzelbauer P. Interferon enhances tumor necrosis factor-induced vascular cell adhesion molecule 1 (CD106) expression in human endothelial cells by an interferon-related factor 1-dependent pathway. J Exp Med 1998 187 : 2023 30.
27. Papi A, Johnston SL. Respiratory epithelial cell expression of vascular cell adhesion molecule-1 and its up-regulation by rhinovirus infection via NF-kappaB and GATA transcription factors. J Biol Chem 1999 274 : 30041 51.
28. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region. Induction by cytokines and phorbol ester. J Immunol 1991 147 : 2777 86.
29. Cybulsky MI, Allan-Motamed M, Collins T. Structure of the murine VCAM1 gene. Genomics 1993 18 : 387 91.
30. Cybulsky MI, Fries JW, Williams AJ et al. Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene. Proc Natl Acad Sci USA 1991 88 : 7859 63.
31. Saito I, Haruta K, Shimuta M et al. Fas ligand-mediated exocrinopathy resembling Sjogren's syndrome in mice transgenic for IL-10. J Immunol 1999 162 : 2488 94.
32. Ishimaru N, Yoneda T, Saegusa K et al. Severe destructive autoimmune lesions with aging in murine Sjogren's syndrome through Fas-mediated apoptosis. Am J Pathol 2000 156 : 1557 64.
33. Fox RI. Sjogren's syndrome: immunobiology of exocrine gland dysfunction. Adv Dent Res 1996 10 : 35 40.
34. Tsubota K, Saito I, Miyasaka N. Expression of granzyme A and perforin in lacrimal gland of Sjogren's syndrome. Adv Exp Med Biol 1994 350 : 637 40.
35. Yednock TA, Cannon C, Fritz LC, Sanchez-Madrid F, Steinman L, Karin N. Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin. Nature 1992 356 : 63 6.
36. Merrill JE, Benveniste EN. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci 1996 19 : 331 8.
37. Rice GP, Hartung HP, Calabresi PA. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 2005 64 : 1336 42.
38. Carter RA, Campbell IK, O'Donnel KL, Wicks IP. Vascular cell adhesion molecule-1 (VCAM-1) blockade in collagen-induced arthritis reduces joint involvement and alters B cell trafficking. Clin Exp Immunol 2002 128 : 44 51.
39. Singh J, Van Vlijmen H, Liao Y et al. Identification of potent and novel alpha4beta1 antagonists using in silico screening. J Med Chem 2002 45 : 2988 93.
40. Foster CA. VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol 1996 98 : S270 7.